Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q16992915> ?p ?o }
Showing triples 1 to 28 of
28
with 100 triples per page.
- Q16992915 subject Q7482753.
- Q16992915 subject Q8529693.
- Q16992915 subject Q9536267.
- Q16992915 abstract "Ezetimibe/atorvastatin (brand name Liptruzet) is a cholesterol lowering combination drug. In the United States, it was approved in May 2013 by the Food and Drug Administration for the treatment of elevated low-density lipoprotein (LDL) in patients with primary or mixed hyperlipidemia as adjunctive therapy to diet. Liptruzet has also been approved to reduce elevated total cholesterol and elevated LDL in patients diagnosed with homozygous familial hypercholesterolemia as an adjunctive treatment to other hyperlipidemia treatments. Some cardiologists opposed the approval, because the combination reduced LDL cholesterol in a clinical trial, but it did not reduce heart disease. A clinical trial studying the endpoints of heart attacks, strokes and heart-related deaths is scheduled to conclude in 2014.".
- Q16992915 atcPrefix "C10".
- Q16992915 atcSuffix "BA05".
- Q16992915 wikiPageWikiLink Q1079120.
- Q16992915 wikiPageWikiLink Q1304270.
- Q16992915 wikiPageWikiLink Q1779868.
- Q16992915 wikiPageWikiLink Q204711.
- Q16992915 wikiPageWikiLink Q2448873.
- Q16992915 wikiPageWikiLink Q28749.
- Q16992915 wikiPageWikiLink Q417997.
- Q16992915 wikiPageWikiLink Q668093.
- Q16992915 wikiPageWikiLink Q7482753.
- Q16992915 wikiPageWikiLink Q8529693.
- Q16992915 wikiPageWikiLink Q9536267.
- Q16992915 wikiPageWikiLink Q954845.
- Q16992915 wikiPageWikiLink Q955332.
- Q16992915 atcPrefix "10.0".
- Q16992915 atcSuffix "BA05".
- Q16992915 type ChemicalSubstance.
- Q16992915 type Drug.
- Q16992915 type ChemicalObject.
- Q16992915 type Thing.
- Q16992915 type Q8386.
- Q16992915 comment "Ezetimibe/atorvastatin (brand name Liptruzet) is a cholesterol lowering combination drug. In the United States, it was approved in May 2013 by the Food and Drug Administration for the treatment of elevated low-density lipoprotein (LDL) in patients with primary or mixed hyperlipidemia as adjunctive therapy to diet.".
- Q16992915 label "Ezetimibe/atorvastatin".